|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0300 CAD | -33.33% |
|
0.00% | -53.85% |
| Market Cap | 3.48M 2.48M 2.16M 2M 1.85M 238M 3.54M 23.86M 9.36M 116M 9.3M 9.1M 401M | P/E 2024 |
-9.02x | P/E 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 3.65M 2.6M 2.27M 2.1M 1.94M 250M 3.72M 25.05M 9.83M 122M 9.77M 9.55M 421M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
84.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -33.33% | ||
| Current month | -33.33% | ||
| 1 month | -25.00% | ||
| 3 months | -14.29% | ||
| 6 months | -50.00% | ||
| Current year | -53.85% |
| 1 week | 0.03 | 0.04 | |
| 1 month | 0.03 | 0.04 | |
| Current year | 0.03 | 0.1 | |
| 1 year | 0.02 | 0.14 | |
| 3 years | 0.02 | 0.2 | |
| 5 years | 0.02 | 0.95 | |
| 10 years | 0.02 | 4.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roberto Fia
CEO | Chief Executive Officer | 55 | - |
Sung Min Myung
DFI | Director of Finance/CFO | 40 | 2019-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Fia
BRD | Director/Board Member | 55 | 2014-11-09 |
Andrew Peterson
CHM | Chairman | 78 | - |
Steve Naraine
BRD | Director/Board Member | - | 2023-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-14 | Sell | Chief Executive Officer | 2,000,000 | 4.3702% | ||
| 05-14 | Sell | Chief Executive Officer | 2,000,000 | 4.3702% | ||
| 03-03 | Tax | Chief Executive Officer | 187,500 | 0.4097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -33.33% | 0.00% | -73.91% | -40.00% | 2.46M | ||
| +0.60% | +1.56% | -10.74% | -7.96% | 13.09B | ||
| +0.90% | +4.39% | -30.67% | -52.54% | 4.96B | ||
| +0.70% | +3.22% | -2.93% | -4.51% | 4.59B | ||
| +4.13% | +8.54% | +14.95% | -31.45% | 4.06B | ||
| +2.50% | -1.75% | +18.72% | -2.76% | 3.8B | ||
| +2.60% | +8.28% | -3.70% | -6.62% | 3.35B | ||
| +1.46% | +1.11% | -7.95% | +7.04% | 3.17B | ||
| +1.47% | +2.12% | -5.92% | -20.92% | 2.43B | ||
| +0.18% | +6.52% | -0.87% | +51.13% | 1.88B | ||
| Average | -1.88% | +3.75% | -10.30% | -10.86% | 4.13B | |
| Weighted average by Cap. | +1.43% | +4.08% | -5.52% | -11.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -388K -276K -241K -223K -206K -26.53M -395K -2.66M -1.04M -12.99M -1.04M -1.01M -44.72M | -1.06M -757K -662K -612K -565K -72.75M -1.08M -7.3M -2.86M -35.62M -2.84M -2.78M -123M |
| Net Debt | 68.01K 48.39K 42.29K 39.09K 36.12K 4.65M 69.25K 466K 183K 2.28M 182K 178K 7.84M | 174K 124K 108K 99.97K 92.36K 11.89M 177K 1.19M 468K 5.82M 465K 455K 20.04M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | $0.0300 | -33.33% | 62,144 |
| 26-07-13 | $0.0450 | +12.50% | 26,000 |
| 26-07-10 | $0.0400 | 0.00% | 56,000 |
| 26-07-09 | $0.0400 | +14.29% | 14,000 |
| 26-07-08 | $0.0350 | +16.67% | 6,000 |
- Stock Market
- Stocks
- CVGR Stock
Select your edition
All financial news and data tailored to specific country editions
















